Ravesteyn, N.T. van

cancer screening breast women model mortality breast cancer mobque study group breast cancer mortality incidence trial overdiagnosi breast cancers result mammography treatment number difference breast cancer incidence estimate children score population reduction mobility diameter health effect strategy interval adjuvant table tumor mammography screening tumour screen study group screening age overdiagnosis rate level control group history frequency breast cancer screening center death validity research stage disparity distribution adjuvant treatment sensitivity control follow-up limitation women 25 years phase adjuvant therapy measure therapy bene fits overdiagnosis estimates mobques 47 netherland estimator survival motor program screening program diagnosis function factor epidemiol trend increase miscan – fadia state